The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 30, 2014

Filed:

Jun. 09, 2010
Applicants:

Anlong Ouyang, Fremont, CA (US);

Aniruddha Patwardhan, Fishers, IN (US);

Lili Arabshahi, Fremont, CA (US);

Inventors:

Anlong Ouyang, Fremont, CA (US);

Aniruddha Patwardhan, Fishers, IN (US);

Lili Arabshahi, Fremont, CA (US);

Assignee:

Microgenics Corporation, Fremont, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); C07D 207/09 (2006.01); C07K 2/00 (2006.01); C07K 16/44 (2006.01); G01N 33/94 (2006.01); C07D 207/16 (2006.01); C07D 207/27 (2006.01); C07D 403/12 (2006.01);
U.S. Cl.
CPC ...
C07K 16/44 (2013.01); G01N 33/9473 (2013.01); C07D 207/16 (2013.01); C07D 207/27 (2013.01); C07D 403/12 (2013.01);
Abstract

Levetiracetam (LEV) derivatives, methods for synthesizing LEV derivatives, and immunodiagnostic assays for LEV. The synthesis methods described herein include chirally-selective, liquid-phase synthesis steps to produce selected LEV derivatives in high-yield. LEV derivatives can include operative groups, such as: immunogenic moieties that can be used to prepare anti-LEV antibodies; antigenic moieties that can be used in immunodiagnostic assays for LEV; or tracer moieties that can be used in immunodiagnostic assays. Additionally, the LEV derivatives can be used in immunodiagnostic assays to compete with LEV for anti-LEV antibodies.


Find Patent Forward Citations

Loading…